Quality assurance in breast cancer brachytherapy: Geographic miss in the interstitial boost treatment of the tumor bed

1996 ◽  
Vol 34 (5) ◽  
pp. 1133-1139 ◽  
Author(s):  
Felix Sedlmayer ◽  
Hassan B.K. Rahim ◽  
H. Dieter Kogelnik ◽  
Christian Menzel ◽  
Florian Merz ◽  
...  
2017 ◽  
Vol 18 (2) ◽  
pp. 67-71 ◽  
Author(s):  
Florian Ebner ◽  
Nikolaus de Gregorio ◽  
Andreas Rempen ◽  
Peter Mohr ◽  
Amelie de Gregorio ◽  
...  

2017 ◽  
Vol 13 (1) ◽  
pp. 4605-4617
Author(s):  
Aly Mahmoud El-Hdidy

Comparisons between three different techniques by which the boost dose was delivered to the tumor bed were carried out , aiming to present the best technique of treatment for right breast cancer patients.In this study, ten right sided breast cancer computed tomography (CT) scans were selected for ten early right breast cancer patients. We made three different treatment plans for each patient CT using three different irradiation techniques to deliver a prescribed boost dose of 10 Gy in 5 fractions to the boost PTV. In the first technique, two tangential photon beams were used, in the second technique we, two oblique photon beams were used and in the third technique, a single electron beam was used. The comparative analyses between the three techniques were performed by comparing the boost PTV- dose volume histograms (DVHs), the ipsilateral breast (right breast) DVHs, the ipsilateral lung (right lung) DVHs and the heart DVHs of the three techniques for each patient. Furthermore the dose that covering 100% , 95% of the volume (D100% , D95%) and the volume covered by 95% of the dose (V95%)of  the boost PTV of all techniques, were calculated for each patient to investigate the dose coverage of the target.Results showed that there were variations of the dose received by tumor bed, right breast and OARs depending on the technique used and the target location and size. A decrease of D100% than 90% of the prescribed dose was observed with the 3rd technique for patients 8, 9 and 10, and was observed with the 2nd technique for patient 5. A reduction of right breast dose was observed when the 3rd technique was use in comparison with the 1st and the 2nd techniques for patients 1, 2, 3, 4, 6 and 8.  Also reduction of right breast was observed when the 2nd technique used in comparison with 1st technique. An increase of lung dose was observed with the 3rd technique for patients 1, 2, 5 and 6, also was observed with 2nd technique in patient 3, 5 and 7. A decrease of lung dose was observed with the 1st technique for patients 2, 4, 5, 6, 7, 8 and 9An individualized treatment, several plans using different irradiation techniques should be developed for each patient individually to reach the best boost PTV dose coverage with minimal OARs’ dose. 


1993 ◽  
Vol 29 ◽  
pp. S41
Author(s):  
K. Vantongelen ◽  
R. Christisens ◽  
M. Ptaszynski ◽  
E. van der Schueren

2011 ◽  
Vol 135 (7) ◽  
pp. 874-881
Author(s):  
Nikita Makretsov ◽  
C. Blake Gilks ◽  
Reza Alaghehbandan ◽  
John Garratt ◽  
Louise Quenneville ◽  
...  

Abstract Context.—External quality assurance and proficiency testing programs for breast cancer predictive biomarkers are based largely on traditional ad hoc design; at present there is no universal consensus on definition of a standard reference value for samples used in external quality assurance programs. Objective.—To explore reference values for estrogen receptor and progesterone receptor immunohistochemistry in order to develop an evidence-based analytic platform for external quality assurance. Design.—There were 31 participating laboratories, 4 of which were previously designated as “expert” laboratories. Each participant tested a tissue microarray slide with 44 breast carcinomas for estrogen receptor and progesterone receptor and submitted it to the Canadian Immunohistochemistry Quality Control Program for analysis. Nuclear staining in 1% or more of the tumor cells was a positive score. Five methods for determining reference values were compared. Results.—All reference values showed 100% agreement for estrogen receptor and progesterone receptor scores, when indeterminate results were excluded. Individual laboratory performance (agreement rates, test sensitivity, test specificity, positive predictive value, negative predictive value, and κ value) was very similar for all reference values. Identification of suboptimal performance by all methods was identical for 30 of 31 laboratories. Estrogen receptor assessment of 1 laboratory was discordant: agreement was less than 90% for 3 of 5 reference values and greater than 90% with the use of 2 other reference values. Conclusions.—Various reference values provide equivalent laboratory rating. In addition to descriptive feedback, our approach allows calculation of technical test sensitivity and specificity, positive and negative predictive values, agreement rates, and κ values to guide corrective actions.


2021 ◽  
Vol 233 (5) ◽  
pp. S31-S32
Author(s):  
David Linshaw ◽  
Utkarsh Shukla ◽  
Naomi Kalliath ◽  
Sydney Tan ◽  
Jaroslaw Hepel ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document